Live Breaking News & Updates on Standard Biotools Investor Relations

Stay updated with breaking news from Standard biotools investor relations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Standard Biotools To Participate In Upcoming Investor Conferences

Standard Biotools To Participate In Upcoming Investor Conferences
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

David Holmes , Michael Egholm , Gilmartin Group , Research Use , Fluidigm Corporation , Somalogic Inc , Standard Biotools Inc , Panel Discussion , Global Healthcare Conference , Wednesday June , Investor Relations , Standard Biotools Investor Relations , Use Label License , License Information ,

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Somalogic Inc , Research Use , Fluidigm Corporation , Standard Biotools Inc , Investor Relations , Standard Biotools Investor Relations , Use Label License , License Information ,

Standard BioTools to Participate in Upcoming Investor Conferences - Standard BioTools (NASDAQ:LAB)

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that ....

United States , Michael Egholm , Fluidigm Corporation , Standard Biotools Inc , Research Use , Annual Healthcare Conference , Chief Executive Officer , Banc Capital Markets Life Sciences , Medtech Investor Forum , Investor Relations , Standard Biotools Investor Relations , Standard Biotools , Mass Cytometry ,

Standard Biotools Reports Second Quarter 2023 Financial Results

Standard Biotools Reports Second Quarter 2023 Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , Peter Denardo , Michael Egholm , Jeff Black , Fluidigm Corporation , Exchange Commission , Research Use , Standard Biotools Inc , First Half , Highlights Compared , Chief Executive Officer , Imaging System , Throughput Genomics System , Chief Financial Officer , Senior Vice President , Chief Legal , Investor Relations , Standard Biotools Investor Relations , Supplemental Financial Information , Forward Looking Statements , Private Securities Litigation Reform Act , Standard Biotool , Standard Biotools , Annual Report , Research Use Only , Months Ended June ,

Standard BioTools Reports Fourth Quarter and Full Year 2022

Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP. ....

United States , Peter Denardo , Michael Egholm , Standard Biotools Inc , Exchange Commission , American Association For Cancer Research , Research Use , Fluidigm Corporation , Chief Executive Officer , Standard Biotools , Mass Cytometry , With Proteomics , Imaging Mass Cytometry , Imaging System , American Association , Cancer Research , Investor Relations , Standard Biotools Investor Relations , Supplemental Financial Information , Regarding Use , Private Securities Litigation Reform Act , Standard Biotool , Emergency Use Authorization , Annual Report , Seriesb Preferred , Nasdaq Lab ,